Global Bispecific Antibodies For Cancer Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	172 Pages	TechNavio	June, 2024	INF19006972

Best Price Guarantee
Price	from $2,500
Length	172 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19006972

Global Bispecific Antibodies For Cancer Market 2024-2028

The bispecific antibodies for cancer market is forecasted to grow by USD 314.3 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the bispecific antibodies for cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, advantages of bispecific antibodies over monoclonal antibodies, and strong pipeline.

Technavio's bispecific antibodies for cancer market is segmented as below:

By Type

CD19 or CD3
CD30 or CD16A

By Distribution Channel

Hospitals
Retail pharmacies
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emerging bispecific antibody generation platforms as one of the prime reasons driving the bispecific antibodies for cancer market growth during the next few years. Also, increase in strategic alliances. and strong r and d in China will lead to sizable demand in the market.

The report on the bispecific antibodies for cancer market covers the following areas:

Bispecific antibodies for cancer market sizing
Bispecific antibodies for cancer market forecast
Bispecific antibodies for cancer market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bispecific antibodies for cancer market vendors that include ABL Bio Inc., AFFIMED N.V., Akeso Inc., Amgen Inc., Aptevo Therapeutics Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Eli Lilly and Co., EPIMAB BIOTHERAPEUTICS INC., F STAR THERAPEUTICS INC., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Mereo BioPharma Group Plc, Merus N.V., Pfizer Inc., Regeneron Pharmaceuticals Inc., TG Therapeutics Inc., Vadilal Industries Ltd., and Y mAbs Therapeutics Inc.. Also, the bispecific antibodies for cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Data Table on Incremental Growth
Market Landscape
- Market ecosystem
  - Table Data Table on - Parent Market
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global Bispecific Antibodies For Cancer Market 2018 - 2022
  - Table Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2018 - 2022 ($ million)
- Type segment analysis 2018 - 2022
- Distribution Channel segment analysis 2018 - 2022
- Geography segment analysis 2018 - 2022
- Country segment analysis 2018 - 2022
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
  - Table Data Table on Type - Market share 2023-2028 (%)
- Comparison by Type
  - Table Data Table on Comparison by Type
- CD19 or CD3 - Market size and forecast 2023-2028
  - Table Data Table on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
- CD30 or CD16A - Market size and forecast 2023-2028
  - Table Data Table on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
- Market opportunity by Type
  - Table Data Table on Market opportunity by Type ($ million)
Market Segmentation by Distribution Channel
- Market segments
  - Table Data Table on Distribution Channel - Market share 2023-2028 (%)
- Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospitals - Market size and forecast 2023-2028
  - Table Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
- Retail pharmacies - Market size and forecast 2023-2028
  - Table Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Online - Market size and forecast 2023-2028
  - Table Data Table on Online - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Online - Year-over-year growth 2023-2028 (%)
- Market opportunity by Distribution Channel
  - Table Data Table on Market opportunity by Distribution Channel ($ million)
Customer Landscape
- Customer landscape overview
Geographic Landscape
- Geographic segmentation
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023-2028
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Data Table on US - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Ireland - Market size and forecast 2023-2028
  - Table Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Ireland - Year-over-year growth 2023-2028 (%)
- China - Market size and forecast 2023-2028
  - Table Data Table on China - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on China - Year-over-year growth 2023-2028 (%)
- Hungary - Market size and forecast 2023-2028
  - Table Data Table on Hungary - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Hungary - Year-over-year growth 2023-2028 (%)
- India - Market size and forecast 2023-2028
  - Table Data Table on India - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on India - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Opportunity/Restraints
- Market drivers
  - Increasing prevalence of cancer
  - Advantages of bispecific antibodies over monoclonal antibodies
  - Strong pipeline
- Market challenges
  - High cost of drugs
  - Late diagnosis leads to poor survival rates
  - Side effects of BLINCYTO
- Impact of drivers and challenges
- Market opportunities/restraints
  - Emerging bispecific antibody generation platforms
  - Increase in strategic alliances.
  - Strong R and D in China
Competitive Landscape
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
Competitive Analysis
- Companies profiled
- Market positioning of companies
- ABL Bio Inc.
- AFFIMED N.V.
- Akeso Inc.
- Amgen Inc.
- Aptevo Therapeutics Inc.
- Astellas Pharma Inc.
- Chugai Pharmaceutical Co. Ltd.
- Eli Lilly and Co.
- EPIMAB BIOTHERAPEUTICS INC.
- F STAR THERAPEUTICS INC.
- F. Hoffmann La Roche Ltd.
- Glenmark Pharmaceuticals Ltd.
- Johnson and Johnson Services Inc.
- Mereo BioPharma Group Plc
- Merus N.V.
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations